Text size

Berkshire Hathaway revealed a fourth-quarter purchase of Merck, Bristol-Myers, and AbbVie, while leaving Pfizer.
Getty Images
Warren Buffett’s Berkshire Hathaway
they recently made major changes to their portfolio, as well as purchases
Verizon Communications
and
Chevron,
and selling some
Apple
stock.
In the fourth quarter, Berkshire (ticker:
BRK.B.
) added to posts in
Merck
(MRK),
Squibb Bristol-Myers
(BMY), and
AbbVie
(ABBV), and invested in
Pfizer
(PFE). The Buffett company continued to cut back as well
Wells Fargo
(WFC) stock and sell everything
PNC Financial Services
(PNC) sections. Elsewhere, Berkshire bought more
Kroger
(KR) and gave his investment in
General motors
(GM).
The Buffett company showed the stock trades, among others, in a form it filed with the Securities and Exchange Commission.
Berkshire Hathaway did not immediately respond to a request for comment on the investment changes.
The company increased its investments in Merck, Bristol-Myers, and AbbVie 28.1% to 28.7 million shares, 11.2% to 33.3 million shares, and 20% to 25.5 million shares, respectively. Berkshire Hathaway sold all 3.7 million Pfizer shares in the fourth quarter they were at the end of the third.
Berkshire Hathaway dropped its Wells Fargo share 59% to 52.4 million shares, and sold its 1.9 million PNC shares.
Buffett’s company increased interest in the Kroger grocery 34.3%, ending 2020 with 33.5 million shares. Berkshire slipped its GM share by 9.4% to 72.5 million shares.
Inside Scoop is Barron’s regular feature covering stock deals with corporate officers and board members – so-called attackers – as well as major shareholders, politicians and other celebrities. Because of their internal status, these investors are required to declare stock trading with the Securities and Exchange Commission or other regulatory bodies..
Write to Ed Lin at [email protected] and follow @BarronsEdLin.